Endometrial Tumor Immune Response: Predictive Biomarker of Response to Immunotherapy.

Mullen, Mary M; Mutch, David G

Mullen, Mary M; Mutch, David G.

Afiliación

Mullen MM; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Washington University School of Medicine and Alvin J. Siteman Cancer Center, St Louis, Missouri.
Mutch DG; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Washington University School of Medicine and Alvin J. Siteman Cancer Center, St Louis, Missouri. mutchd@wustl.edu.

Clin Cancer Res ; 25(8): 2366-2368, 2019 04 15.

Article en En | MEDLINE | ID: mdl-30692101

ABSTRACT

ABSTRACT

The tumor-specific immune response in endometrial cancer is variable within molecular subtypes. Thus, the tumor immune response offers a novel biomarker, separate from molecular subtypes, to predict which patients might respond to immunotherapy.See related article by Talhouk et al., p. 2537.

Asunto(s)

Neoplasias Endometriales; Inmunoterapia; Biomarcadores; Femenino; Humanos; Factores Inmunológicos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Endometriales / Inmunoterapia Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google